Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 54 | 0 | 5 | 0 | €107.40 | €148.44 | 38.212% |
| Ionis Pharmaceuticals Inc. | 51 | 1 | 4 | 0 | €63.74 | €77.41 | 21.445% |
| Tenet Healthcare | 47 | 0 | 0 | 0 | €164.00 | €193.52 | 18.002% |
| Alnylam Pharmace. | 46 | 0 | 3 | 0 | €283.30 | €428.30 | 51.182% |
| Jazz Pharmaceuticals plc | 35 | 0 | 1 | 0 | €168.65 | €176.77 | 4.815% |
| Acadia Pharmaceuticals | 34 | 1 | 1 | 0 | €18.41 | €28.15 | 52.919% |
| United Therapeutics | 32 | 1 | 4 | 0 | €491.00 | €507.66 | 3.393% |
| Exelixis Inc. | 30 | 1 | 0 | 0 | €37.37 | €42.21 | 12.977% |
| Merit Medical Systems | 27 | 0 | 3 | 0 | ? | €90.95 | 52.850% |
| PTC Therapeutics Inc. | 28 | 1 | 1 | 0 | ? | €67.74 | 14.662% |
| Ultragenyx Pharmaceutical Inc. | 24 | 0 | 0 | 0 | ? | €55.67 | 179.735% |
| Charles River Labs Intl | 23 | 0 | 1 | 0 | €151.60 | €165.88 | 9.417% |
| Bio-Techne Corp. | 21 | 0 | 1 | 0 | €47.38 | €60.82 | 28.373% |
| Arrowhead Pharmaceuticals Inc. | 21 | 0 | 1 | 0 | €53.78 | €69.18 | 28.630% |
| Haemonetics Corp. | 21 | 0 | 1 | 0 | €49.40 | €75.91 | 53.670% |
| Halozyme Therapeutics Inc. | 19 | 2 | 0 | 0 | €57.14 | €70.40 | 23.211% |
| Alkermes plc | 17 | 0 | 1 | 0 | ? | €37.89 | 33.420% |
| Iovance Biotherapeutics Inc. | 18 | 2 | 2 | 0 | €3.06 | €10.67 | 249.221% |
| Agios Pharmaceuticals Inc. | 15 | 0 | 0 | 0 | €28.20 | €36.75 | 30.337% |
| Bruker Corp. | 14 | 1 | 1 | 0 | €33.50 | €43.42 | 29.597% |
| Xencor Inc. | 15 | 2 | 0 | 0 | ? | €22.44 | 120.031% |
| LivaNova plc | 12 | 0 | 0 | 0 | ? | €59.82 | 9.765% |
| Masimo Corp. | 12 | 0 | 0 | 0 | €152.00 | €171.48 | 12.816% |
| Icon plc | 12 | 0 | 1 | 0 | €93.92 | €191.52 | 103.918% |
| West Pharmaceutical Services Inc. | 12 | 0 | 0 | 0 | €216.60 | €297.60 | 37.398% |